Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance.
Cooper
Angela
A
National Collaborating Centre for Primary Care, Royal College of General Practitioners, London SW7 1PU.
O'Flynn
Norma
N
D000328:Adult; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D003376:Counseling; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008019:Life Style; D008297:Male; D010353:Patient Education as Topic / Q000379:methods; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000379:methods
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D002784:Cholesterol